Welcome to our dedicated page for Veeva Systems news (Ticker: VEEV), a resource for investors and traders seeking the latest updates and insights on Veeva Systems stock.
Veeva Systems Inc. (NYSE: VEEV) is a global leader in cloud-based software solutions specifically tailored for the life sciences industry. Headquartered in the San Francisco Bay Area, Veeva Systems provides innovative technology that helps pharmaceutical and biotech companies streamline their operations, ensure compliance, and bring products to market faster. Veeva's product offerings address key operational and regulatory needs, ranging from customer relationship management (CRM) to content management and data analytics.
Two of the company's flagship products include Veeva CRM and Veeva Vault. Veeva CRM is designed for companies with a salesforce, providing tools to manage customer interactions more efficiently. Meanwhile, Veeva Vault is a versatile content management platform that supports various functions such as clinical trials, regulatory submissions, and quality management within life sciences companies.
Veeva serves a diverse customer base, ranging from emerging biotechs to some of the world's largest pharmaceutical companies. Its commitment to product excellence, customer success, and continuous innovation is evident as Veeva frequently updates its offerings to meet the evolving needs of the industry. Recently, Veeva announced that Boehringer Ingelheim has selected Veeva Vault Clinical and Veeva Vault RIM applications to streamline clinical execution and improve regulatory management in its animal health business unit.
Another notable achievement for Veeva was the launch of the Veeva AI Partner Program, designed to help partners integrate Generative AI solutions seamlessly with Veeva Vault applications. This initiative highlights Veeva's ongoing efforts to leverage advanced technologies to enhance its product ecosystem. Furthermore, the introduction of Veeva Vault CRM Campaign Manager aims to simplify and speed up non-personal promotion to healthcare professionals, ensuring consistent and compliant marketing efforts.
Financially, Veeva Systems has shown strong performance with its fiscal year 2024 results reflecting robust growth. The company continues to invest in its innovation engine and strategic partnerships, setting the stage for sustained, profitable growth. Veeva's recent financial outlook for fiscal year 2025 and first quarter results for 2024 further underline its market leadership and operational excellence.
For more information about Veeva Systems, its products, and latest updates, visit www.veeva.com.
Veeva Systems has launched the Veeva Digital Trials Platform, a technology ecosystem aimed at transforming clinical trial execution. This platform connects patients, research sites, and trial sponsors, enhancing data accuracy and diversity in trials. Key components include the Vault Clinical Suite, SiteVault Free, and MyVeeva for Patients. Early adopters, including major pharma companies, are already utilizing the platform to streamline operations and improve collaboration.
Veeva Systems (NYSE: VEEV) will hold a virtual Financial Analyst and Investor Day on October 28, 2021, from 9:00 a.m. PT to 11:00 a.m. PT. The event will be streamed live on the company's investor relations website, with an archived webcast available later. Registration for the event can be completed online. Veeva's commitment to the life sciences sector includes serving over 1,000 customers and prioritizing stakeholders' interests.
Veeva Systems announced that Celerion has adopted Veeva eConsent for its Phase I clinical trials, transitioning to a digital informed consent process. This shift aims to streamline participant engagement and ensure compliance with regulatory requirements. Over 200 subjects have been consented using this solution. The transition received positive feedback from study teams and participants, highlighting improved comprehension and reduced administrative burdens. Celerion also utilizes Veeva SiteVault for managing informed consent forms, enhancing visibility into consent status.
LEO Pharma and Veeva Systems have announced a strategic partnership aimed at enhancing clinical trials through a patient-centric, paperless approach. LEO Pharma will standardize its operations using Veeva's Clinical Operations Suite, including various integrated clinical products. Key benefits expected include a 25% reduction in clinical trial costs and duration, while improving patient experience and data accuracy. This collaboration aligns with LEO Pharma’s 2030 strategy to expedite innovative treatment delivery.
Veeva Systems (NYSE: VEEV) unveiled the Veeva Vault LIMS, a new cloud application aimed at enhancing quality control lab operations. This addition to the Vault Quality Suite will connect lab functions with the quality ecosystem, streamlining processes for faster batch releases and lower inventory costs. Industry leaders highlight the solution’s potential to improve lab productivity and accelerate testing accuracy. Vault LIMS is scheduled for launch in the second half of 2022.
Veeva Systems (NYSE: VEEV) announced that ConvaTec has chosen Veeva Vault CDMS for electronic data capture in a study focused on detecting wound infections. This proof-of-concept study will evaluate the effectiveness of a combination of biomarkers—wound pH, human neutrophil elastase (HNE), and myeloperoxidase (MPO)—to detect infections. The international study aims to enroll 75 to 90 subjects over approximately 20 weeks. Veeva MedTech supports ConvaTec's efforts with its unified data management solution.
Emmes has partnered with Veeva Systems (NYSE: VEEV) to standardize on Veeva Development Cloud applications, enhancing speed and compliance in clinical research. This collaboration aims to improve operational efficiency across various functional areas, aiding in the growth of Emmes as it expands into new markets. Veeva's cloud solutions will facilitate better collaboration with sponsors and regulatory compliance. Emmes plans to implement several Veeva applications, thereby establishing a unified technology platform for effective clinical and quality management.
Veeva Systems (NYSE: VEEV) announced the launch of Veeva Vault Validation Management, a new application designed to enhance validation lifecycle management for life sciences companies. This solution streamlines validation processes, reduces manual efforts, and supports electronic execution to improve compliance and efficiency. Veeva Vault Validation Management integrates with other Veeva Vault Quality Suite applications, enabling better documentation and data integrity. The application is expected to be available in the second half of 2022, aiming to optimize quality management across the life sciences value chain.
Veeva Systems (NYSE: VEEV) announced the 2021 Veeva R&D and Quality Summit Connect, featuring keynote speakers from Bristol Myers Squibb, GSK, and Roche. This online event on October 14, 2021, aims to enhance knowledge sharing in life sciences, with over 75 sessions focusing on advancements in digital trials. Industry leaders will discuss operational improvements and compliance strategies. Veeva emphasizes its commitment to innovation and customer success, serving over 1,100 clients.
Veeva Systems (NYSE: VEEV) has announced its 2021 Quality & Regulatory Global Summit, set to begin on October 18, 2021. The virtual summit will feature over 15 sessions with industry leaders from companies like Unilever, BASF, and Estée Lauder. Discussions will focus on modernizing business initiatives including product compliance and sustainability. The event is complimentary for Veeva customers and qualified industry professionals. Veeva, known for its cloud software solutions, aims to support industries like consumer goods and chemicals in overcoming regulatory challenges.
FAQ
What is the current stock price of Veeva Systems (VEEV)?
What is the market cap of Veeva Systems (VEEV)?
What does Veeva Systems Inc. do?
Where is Veeva Systems Inc. headquartered?
What are Veeva's main products?
Who are Veeva Systems' customers?
What recent partnerships has Veeva announced?
What is the Veeva AI Partner Program?
How has Veeva performed financially recently?
What is Veeva Vault CRM Campaign Manager?
What industry does Veeva Systems primarily serve?
How does Veeva contribute to the life sciences industry?
